The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Antihyperglycemic Effects of Short Term Resveratrol Supplementation in Type 2 Diabetic Patients
Open accessAbstract
The objective of this study was to examine the effectiveness of resveratrol in lowering blood glucose in the presence of standard antidiabetic treatment in patients with type 2 diabetes, in a randomized placebo-controlled double-blinded parallel clinical trial. A total of 66 subjects with type 2 diabetes were enrolled in this study and randomly assigned to intervention group which was supplemented with resveratrol at a dose 1 g/day for 45 days and control group which received placebo tablets. Body weight, blood pressure, fasting blood glucose, haemoglobin A1c, insulin, homeostatic assessments for insulin resistance, triglycerides, total cholesterol, low density lipoprotein, high density lipoprotein, and markers of liver and kidney damage were measured at baseline and after 45 days of resveratrol or placebo supplementation. Resveratrol treatment significantly decreased systolic blood pressure, fasting blood glucose, haemoglobin A1c, insulin, and insulin resistance, while HDL was significantly increased, when compared to their baseline levels. On the other hand, the placebo group had slightly increased fasting glucose and LDL when compared to their baseline levels. Liver and kidney function markers were unchanged in the intervention group. Overall, this study showed that resveratrol supplementation exerted strong antidiabetic effects in patients with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Use and Abuse of HOMA Modeling
Wallace, T. M., Levy, J. C., & Matthews, D. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1487 · Cited by 5,114
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Timmers, S., Konings, E., Bilet, L., Houtkooper, R. H., van de Weijer, T., Goossens, G. H., Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.002 · Cited by 1,320
McColl, E., Jacoby, A., Thomas, L., Soutter, J., Bamford, C., Steen, N., Thomas, R., Harvey, E., Garratt, A., & Bond, J. (2001) · Health Technology Assessment · doi:10.3310/hta5310 · Cited by 788
Brown, V. A., Patel, K. R., Viskaduraki, M., Crowell, J. A., Perloff, M., Booth, T. D., Vasilinin, G., Sen, A., Schinas, A. M., Piccirilli, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2364 · Cited by 688
Brasnyó, P., Molnár, G. A., Mohás, M., Markó, L., Laczy, B., Cseh, J., Mikolás, E., Szijártó, I. A., Mérei, Á., Halmai, R., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114511000316 · Cited by 678
Approved IFCC reference method for the measurement of HbA1c in human blood
Jeppsson, J.-O., Kobold, U., Barr, J., Finke, A., Hoelzel, W., Hoshino, T., Miedema, K., Mosca, A., Mauri, P., Paroni, R., et al. (2002) · Clinical Chemistry and Laboratory Medicine · doi:10.1515/cclm.2002.016 · Cited by 655
Resveratrol and health—A comprehensive review of human clinical trials
Smoliga, J. M., Baur, J. A., & Hausenblas, H. A. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100143 · Cited by 594
Brookes, S. T., Whitley, E., Peters, T. J., Mulheran, P. A., Egger, M., & Davey Smith, G. (2001) · Health Technology Assessment · doi:10.3310/hta5330 · Cited by 580
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Bhatt, J. K., Thomas, S., & Nanjan, M. J. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.003 · Cited by 475
Current views on type 2 diabetes
Lin, Y., & Sun, Z. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0260 · Cited by 457
High-Dose Resveratrol Supplementation in Obese Men
Poulsen, M. M., Vestergaard, P. F., Clasen, B. F., Radko, Y., Christensen, L. P., Stødkilde-Jørgensen, H., Møller, N., Jessen, N., Pedersen, S. B., & Jørgensen, J. O. L. (2013) · Diabetes · doi:10.2337/db12-0975 · Cited by 455
What Is New for an Old Molecule? Systematic Review and Recommendations on the Use of Resveratrol
Vang, O., Ahmad, N., Baile, C. A., Baur, J. A., Brown, K., Csiszar, A., Das, D. K., Delmas, D., Gottfried, C., Lin, H.-Y., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019881 · Cited by 437
Glycemic control and complications in type 2 diabetes mellitus
Stolar, M. (2010) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.12.004 · Cited by 356 · cited 1×
“Progression of uncontrolled diabetes culminates inmicrovascular (retinopathy, nephropathy, and neuropathy) and macrovascular (cardiac, cerebral, and peripheral vascular disease) complications and premature death [3, 4].”
BackgroundThe worldwide diabetes epidemic
Lam, D. W., & LeRoith, D. (2012) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e328350583a · Cited by 316
Pilot study of resveratrol in older adults with impaired glucose tolerance
Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., & Barzilai, N. (2012) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glr235 · Cited by 281
Anti‐diabetic effects of resveratrol
Szkudelski, T., & Szkudelska, K. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05844.x · Cited by 240
Quantifying the Effect of Metformin Treatment and Dose on Glycemic Control
Hirst, J. A., Farmer, A. J., Ali, R., Roberts, N. W., & Stevens, R. J. (2012) · Diabetes Care · doi:10.2337/dc11-1465 · Cited by 204
Cellular and molecular effects of resveratrol in health and disease
Yu, W., Fu, Y., & Wang, W. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23431 · Cited by 182
Thandapilly, S. J., Wojciechowski, P., Behbahani, J., Louis, X. L., Yu, L., Juric, D., Kopilas, M. A., Anderson, H. D., & Netticadan, T. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2009.228 · Cited by 172
Self-citationType 2 Diabetes: An Epidemic Requiring Global Attention and Urgent Action
Herman, W. H., & Zimmet, P. (2012) · Diabetes Care · doi:10.2337/dc12-0298 · Cited by 161
Do, G., Jung, U. J., Park, H., Kwon, E., Jeon, S.-M., McGregor, R. A., & Choi, M. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200067 · Cited by 156
Central Administration of Resveratrol Improves Diet-Induced Diabetes
Ramadori, G., Gautron, L., Fujikawa, T., Vianna, C. R., Elmquist, J. K., & Coppari, R. (2009) · Endocrinology · doi:10.1210/en.2009-0528 · Cited by 142
Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis
Haghdoost, A. A., Kermani, M. R., Sadghirad, B., & Baradaran, H. R. (2009) · Eastern Mediterranean Health Journal · doi:10.26719/2009.15.3.591 · Cited by 138
A Comparison of HbA1c and Fasting Blood Sugar Tests in General Population.
Ghazanfari, Z., Haghdoost, A. A., Mohammad‐Alizadeh‐Charandabi, S., Atapour, J., & Zolala, F. (2010) · Europe PMC (PubMed Central) · Cited by 128
Juric, D., Wojciechowski, P. W., Das, D. K., & Netticadan, T. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00852.2006 · Cited by 115
Self-citationSapin, R., Galudec, V. L., Gasser, F., Pinget, M., & Grucker, D. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.3.602 · Cited by 95
Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type‐2 diabetes
Sharma, S., Misra, C. S., Arumugam, S., Roy, S., Shah, V., Davis, J. A., Shirumalla, R. K., & Ray, A. (2010) · Phytotherapy Research · doi:10.1002/ptr.3221 · Cited by 88
Type 2 diabetes and impaired fasting blood glucose in rural Bangladesh: a population-based study
Hussain, A., Vaaler, S., Sayeed, M. A., Mahtab, H., Ali, S. M. K., & Khan, A. K. A. (2006) · European Journal of Public Health · doi:10.1093/eurpub/ckl235 · Cited by 86
Synergistic effects of metformin, resveratrol, and hydroxymethylbutyrate on insulin sensitivity
Zemel, M. B., & Bruckbauer (2013) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s40840 · Cited by 81
Screening for type 2 diabetes in the Iranian national programme: a preliminary report
Azizi, F., Guoya, M. M., Vazirian, P., Dolatshati, P., & Habibian, S. (2003) · Eastern Mediterranean Health Journal · doi:10.26719/2003.9.5-6.1122 · Cited by 69
Thandapilly, S. J., Louis, X. L., Yang, T., Defries, D. M., Yu, L., Zhang, S., Wigle, J. T., Kardami, E., Zahradka, P. C., Taylor, C. G., et al. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.06.042 · Cited by 61
Self-citationSone, H., Tanaka, S., Tanaka, S., Iimuro, S., Ishibashi, S., Oikawa, S., Shimano, H., Katayama, S., Ohashi, Y., Akanuma, Y., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1412 · Cited by 57
Resveratrol: A Multifunctional Cytoprotective Molecule
Juhász, B., Varga, B., Gesztelyi, R., et al. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110793262079 · Cited by 56
Louis, X. L., Thandapilly, S. J., Mohankumar, S. K., Yu, L., Taylor, C. G., Zahradka, P. C., & Netticadan, T. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.06.010 · Cited by 49
Self-citationInsulin resistance, prehypertension, hypertension and blood pressure values in paediatric age
Genovesi, S., Brambilla, P., Giussani, M., Galbiati, S., Mastriani, S., Pieruzzi, F., Stella, A., Valsecchi, M. G., & Antolini, L. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834e4aaa · Cited by 37
Plasma lipids and antidiabetic agents: a brief overview
Keidan, B., Hsia, J. A., & Katz, R. J. (2002) · The British Journal of Diabetes · doi:10.1177/14746514020020011801 · Cited by 27
The increasing epidemiology of diabetes and review of current treatment algorithms.
Freeman, J. S. (2010) · PubMed · Cited by 18
Cited by
Antioxidant effects of resveratrol in the cardiovascular system
Xia, N., Daiber, A., Förstermann, U., & Li, H. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13492 · Cited by 574
Health benefits of resveratrol: Evidence from clinical studies
Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523
Resveratrol for cancer therapy: Challenges and future perspectives
Ren, B., Kwah, M. X.-Y., Liu, C., Ma, Z., Shanmugam, M. K., Ding, L., Xiang, X., Ho, P. C.-L., Wang, L., Ong, P. S., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.001 · Cited by 495
Sirtuins and NAD + in the Development and Treatment of Metabolic and Cardiovascular Diseases
Kane, A. E., & Sinclair, D. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312498 · Cited by 487
Natural products for the treatment of type 2 diabetes mellitus: Pharmacology and mechanisms
Xu, L., Li, Y., Dai, Y., & Peng, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.015 · Cited by 452
Metadata
- Authors
- Movahed, A., Nabipour, I., Lieben Louis, X., Thandapilly, S. J., Yu, L., Kalantarhormozi, M., Rekabpour, S. J., & Netticadan, T.
- Venue
- Evidence-Based Complementary and Alternative Medicine
- Publisher
- Wiley
- Published
- 2013
- Volume
- 2013
- Pages
- 1-11
- ISSN
- 1741-427X (ISSN-L)
- 1741-4288
- OpenAlex
- W2071062711
- Cited by
- 257
- References
- 40
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.